Table 2.
FEP based binding free energy calculations for p53-MDM2 inhibitors.
S. No. | Complex/PDBID | IC50/Ki (nM) |
ΔGcalculated a (Kcal/mol) |
ΔGcorrection (Kcal/mol) |
ΔGcorrected
b (Kcal/mol) |
∆Gexperimental (Kcal/mol) |
Ref. |
---|---|---|---|---|---|---|---|
1 | 6GGN | 0.08 | −17.05 ± 0.33 | 1.04 ± 0.07 | −16.01 ± 0.4 | −13.76 c | [36] |
2 | 5OC8 | 0.21 | −14.91 ± 0.78 | 1.15 ± 0.08 | −13.76 ± 0.86 | −13.18 d | [37] |
3 | 4ZYF | 1.3 | −12.89 ± 0.39 | 1.34 ± 0.29 | −11.55 ± 0.68 | −12.11 d | [38] |
4 | 5LAZ | 4 | −12.57 ± 0.35 | 1.0 ± 0.03 | −11.57 ± 0.38 | −11.44 c | [39] |
5 | 5LAY | 34 | −12.04 ± 0.29 | 0.98 ± 0.1 | −11.06 ± 0.39 | −10.19 c | [39] |
6 | 5LAW | 80 | −11.06 ± 0.36 | 1.00 ± 0.03 | −10.06 ± 0.39 | −9.68 c | [39] |
7 | WK298 | 109 | −10.885 ± 0.33 | 1.15 ± 0.08 | −9.73 ± 0.41 | −9.49 d | [21] |
8 | 3TJ2 | 300 | −11.64 ± 0.39 | 1.028 ± 0.09 | −10.64 ± 0.48 | −8.89 d | [40] |
9 | 4MDN | 600 | −9.79 ±0.40 | 1.19 ± 0.18 | −8.6 ± 0.58 | −8.47 d | [41] |
10 | 5LAV | 819 | −15.80 ± 0.25 | 1.15 ± 0.08 | −14.65 ± 0.33 | −8.29 c | [39] |
11 | 4MDQ | 900 | −12.52 ± 0.42 | 1.66 ± 0.18 | −10.86 ± 0.6 | −8.24 d | [41] |
12 | 3LBK | 916 | −10.49 ± 0.28 | 1.12 ± 0.03 | −9.37 ± 0.31 | −8.22 d | [21] |
13 | 4JV7 | 1000 | −14.56 ± 0.29 | 1.42 ± 0.18 | −13.14 ± 0.47 | −8.63 c | [42] |
14 | 4JV9 | 1800 | −15.73 ± 0.29 | 1.62 ± 0.27 | −14.11 ± 0.56 | −8.27 c | [42] |
Mean absolute error: a 3.08, b 1.95; root mean square error a 3.80, b 2.83; c ΔGexperimental was calculated using IC50 and d ΔGexperimental was calculated using Ki values. The standard error in correction term is derived from standard error of the mean (Table S3).